Tekla Capital Management LLC Argenx Se Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Argenx Se stock. As of the latest transaction made, Tekla Capital Management LLC holds 65,553 shares of ARGX stock, worth $37 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

65,553

Previous 88,310 25.77%

Holding current value

$37 Million

Previous $32.9 Million 22.35%

% of portfolio

1.01%

Previous 1.26%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$360.14 - $422.58 $8.2 Million - $9.62 Million	-22,757 Reduced 25.77%	65,553 $25.5 Million
Q1 2023 May 10, 2023	BUY	$334.23 - $403.65 $1.43 Million - $1.73 Million	4,289 Added 5.1%	88,310 $32.9 Million
Q4 2022 Feb 10, 2023	BUY	$342.17 - $402.31 $2.53 Million - $2.97 Million	7,386 Added 9.64%	84,021 $31.8 Million
Q3 2022 Nov 01, 2022	BUY	$343.2 - $395.75 $13.1 Million - $15.1 Million	38,179 Added 99.28%	76,635 $27.1 Million
Q3 2021 Nov 12, 2021	SELL	$295.0 - $350.58 $10.6 Million - $12.6 Million	-35,954 Reduced 48.32%	38,456 $11.6 Million
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $2.59 Million - $3.22 Million	10,066 Added 15.64%	74,410 $22.4 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $712,873 - $1.01 Million	2,657 Added 4.31%	64,344 $17.7 Million
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $3.6 Million - $4.55 Million	16,710 Added 37.15%	61,687 $16.2 Million
Q4 2019 Feb 13, 2020	BUY	$106.59 - $164.21 $1.16 Million - $1.79 Million	10,929 Added 32.1%	44,977 $7.22 Million
Q3 2019 Nov 13, 2019	BUY	$113.31 - $150.51 $642,127 - $852,940	5,667 Added 19.97%	34,048 $3.88 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $2.81 Million - $3.82 Million	28,381 New	28,381 $3.54 Million
Q4 2018 Feb 13, 2019	SELL	$63.81 - $109.82 $969,146 - $1.67 Million	-15,188 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$75.5 - $96.63 $1.79 Million - $2.29 Million	-23,743 Reduced 60.99%	15,188 $1.15 Million
Q1 2018 May 14, 2018	SELL	$56.95 - $85.19 $429,118 - $641,906	-7,535 Reduced 16.22%	38,931 $3.13 Million
Q4 2017 Feb 14, 2018	SELL	$22.57 - $63.56 $644,012 - $1.81 Million	-28,534 Reduced 38.05%	46,466 $2.93 Million
Q2 2017 Aug 14, 2017	BUY	N/A	75,000	75,000 $1.59 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Argenx Se Transaction History